These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2214880)

  • 41. Pilot interferon-beta trial in children with chronic hepatitis B who had previously not responded to interferon-alpha therapy.
    Ruíz-Moreno M; Fernández P; Leal A; Bartolomé J; Castillo I; Oliva H; Carreño V
    Pediatrics; 1997 Feb; 99(2):222-5. PubMed ID: 9024450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic viral hepatitis--benefits of current therapies.
    Hoofnagle JH; Lau D
    N Engl J Med; 1996 May; 334(22):1470-1. PubMed ID: 8618588
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: a prospective, multicenter, randomized, open-label study.
    Kim BH; Lee YJ; Kim W; Yoon JH; Jung EU; Park SJ; Kim YJ; Lee HS
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1048-55. PubMed ID: 22726105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chronic infection due to hepatitis B virus in patients less than 16 years of age: therapeutic approach by means of interferon alfa-2b].
    Vetencourt R; Oropeza F; de Armas J; Cordero I; de Silva M; Machado I; Vetencourt M; Mendoza J
    G E N; 1990; 44(4):353-60. PubMed ID: 2152277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human lymphoblastoid interferon for the treatment of chronic hepatitis B. A randomized controlled trial.
    Mazzella G; Saracco G; Rizetto M; Amed MA; Gonzàlez Quintela A; Rosina F; Barbara L; Roda E
    Am J Med; 1988 Aug; 85(2A):141-2. PubMed ID: 3044077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment of chronic hepatitis B with interferon alpha-2b].
    Baumgarten R; Müller R; Markus R; Hintsche-Kilger B; Fengler JD; Meisel H
    Gastroenterol J; 1990; 50(3):124-8. PubMed ID: 2288653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitis.
    Visco G; Alba L; Grisetti S; Guarascio P; Narciso P; Sette P; Struglia C; Tossini G; Tozzi V
    Gut; 1993; 34(2 Suppl):S107-8. PubMed ID: 8314472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Results of long term interferon treatment in non A non B/C chronic active hepatitis. The French Group for the study of NANB/C chronic hepatitis treatment.
    Métreau JM
    Gut; 1993; 34(2 Suppl):S112-3. PubMed ID: 8314474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [HBsAg loss with Pegylated-interferon alfa-2a in hepatitis B patients with partial response to nucleos(t)-ide analog: new switch study].
    Hu P; Shang J; Zhang WH; Gong GZ; Li YG; Chen XY; Jiang JN; Xie Q; Dou XG; Sun YT; Li YF; Liu YX; Liu GZ; Ma DW; Chi XL; Tang H; Li XO; Xie Y; Chen XP; Jiang JJ; Zha P; Hou JL; Gao ZL; Fan HM; Ding JG; Zhang DZ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2018 Oct; 26(10):756-764. PubMed ID: 30481882
    [No Abstract]   [Full Text] [Related]  

  • 50. 48 weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection.
    Hui CK; Lai LS; Lam P; Zhang HY; Fung TT; Lai ST; Wong WM; Lo CM; Fan ST; Leung N; Lau GK;
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1171-8. PubMed ID: 16611278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.
    Brunetto MR; Moriconi F; Bonino F; Lau GK; Farci P; Yurdaydin C; Piratvisuth T; Luo K; Wang Y; Hadziyannis S; Wolf E; McCloud P; Batrla R; Marcellin P
    Hepatology; 2009 Apr; 49(4):1141-50. PubMed ID: 19338056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa.
    Lau DT; Everhart J; Kleiner DE; Park Y; Vergalla J; Schmid P; Hoofnagle JH
    Gastroenterology; 1997 Nov; 113(5):1660-7. PubMed ID: 9352870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients.
    Zylberberg H; Jiang J; Pialoux G; Driss F; Carnot F; Dubois F; Brechot C; Berthelot P; Pol S
    Gastroenterol Clin Biol; 1996; 20(11):968-71. PubMed ID: 9119186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: a randomised open-label trial (OSST trial).
    Ning Q; Han M; Sun Y; Jiang J; Tan D; Hou J; Tang H; Sheng J; Zhao M
    J Hepatol; 2014 Oct; 61(4):777-84. PubMed ID: 24915612
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.
    Marcellin P; Lau GK; Bonino F; Farci P; Hadziyannis S; Jin R; Lu ZM; Piratvisuth T; Germanidis G; Yurdaydin C; Diago M; Gurel S; Lai MY; Button P; Pluck N;
    N Engl J Med; 2004 Sep; 351(12):1206-17. PubMed ID: 15371578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of liver disease in healthy hepatitis B surface antigen carriers during interferon-alpha treatment.
    Rodríguez-Iñigo E; Bartolomé J; López-Alcorocho JM; Contonat T; Oliva H; Carreño V
    J Med Virol; 1997 Sep; 53(1):76-80. PubMed ID: 9298736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical efficacy of various antiviral-based strategies to treat chronic hepatitis patients with positivity for hepatitis B e antigen and rtN236T mutation].
    Yue W; Yuan H; Mao XR; Deng YD; Chen L
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):184-8. PubMed ID: 23967738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, antiHCV-positive patients.
    Villa E; Grottola A; Trande P; Seium Y; Rebecchi AM; Dugani A; Manenti F
    Lancet; 1993 May; 341(8857):1413. PubMed ID: 7684479
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy and safety of peginterferon alpha-2a (40KD) in HBeAg-positive chronic hepatitis B patients.
    Caruntu FA; Streinu-Cercel A; Gheorghe LS; Grigorescu M; Sporea I; Stanciu C; Andronescu D; Voinea F; Diculescu M; Oproiu A; Voiosu R
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):425-31. PubMed ID: 20076814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous steroids/interferon therapy in chronic hepatitis B.
    Causse X; Godinot H; Chevallier M; Chossegros P; Zoulim F; Zarski JP; Meschiewitz C; Albrecht J; Trépo C
    J Hepatol; 1993 Jan; 17(1):128-9. PubMed ID: 8445212
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.